Zobrazeno 1 - 10
of 78
pro vyhledávání: '"van Bodegraven, A. A."'
Autor:
Marie Helene I. Joosten, Flora M. Tan, Daphne Krebbers, Peter J.M. Weijs, Maarten R. Soeters, Jolein Rmc Jorissen, Nicolette J. Wierdsma, Loes H. van Aken, Hinke Kruizenga, Ad A. van Bodegraven, Lotte Aml Konings
Publikováno v:
Clinical Nutrition ESPEN, 43(June), 369-376. Elsevier Ltd
Clinical Nutrition ESPEN, 43, 369-376. Elsevier Ltd.
Clinical nutrition ESPEN, 43, 369-376. Elsevier Limited
Wierdsma, N J, Kruizenga, H M, Konings, L AML, Krebbers, D, Jorissen, J RMC, Joosten, M H I, van Aken, L H, Tan, F M, van Bodegraven, A A, Soeters, M R & Weijs, P JM 2021, ' Poor nutritional status, risk of sarcopenia and nutrition related complaints are prevalent in COVID-19 patients during and after hospital admission ', Clinical Nutrition ESPEN, vol. 43, no. June, pp. 369-376 . https://doi.org/10.1016/j.clnesp.2021.03.021
Clinical Nutrition Espen
Clinical Nutrition ESPEN, 43, 369-376. Elsevier Ltd.
Clinical nutrition ESPEN, 43, 369-376. Elsevier Limited
Wierdsma, N J, Kruizenga, H M, Konings, L AML, Krebbers, D, Jorissen, J RMC, Joosten, M H I, van Aken, L H, Tan, F M, van Bodegraven, A A, Soeters, M R & Weijs, P JM 2021, ' Poor nutritional status, risk of sarcopenia and nutrition related complaints are prevalent in COVID-19 patients during and after hospital admission ', Clinical Nutrition ESPEN, vol. 43, no. June, pp. 369-376 . https://doi.org/10.1016/j.clnesp.2021.03.021
Clinical Nutrition Espen
BACKGROUND AND AIMS: Patients with COVID-19 infection presents with a broad clinical spectrum of symptoms and complications. As a consequence nutritional requirements are not met, resulting in weight- and muscle loss, and malnutrition. The aim of the
Autor:
Jochem C. G. Scheijmans, Alexander B. J. Borgstein, Carl A. J. Puylaert, Wouter J. Bom, Said Bachiri, Eduard A. van Bodegraven, Amarins T. A. Brandsma, Floor M. ter Brugge, Steve M. M. de Castro, Roy Couvreur, Lotte C. Franken, Marcia P. Gaspersz, Michelle R. de Graaff, Hannah Groenen, Suzanne C. Kleipool, Toon J. L. Kuypers, Milou H. Martens, David M. Mens, Ricardo G. Orsini, Nando J. M. M. Reneerkens, Thomas Schok, Wouter J. A. Sedee, Shahzad Tavakoli Rad, José H. Volders, Pepijn D. Weeder, Jan M. Prins, Hester A. Gietema, Jaap Stoker, Suzanne S. Gisbertz, Marc G. H. Besselink, Marja A. Boermeester, the SCOUT Collaboarative Study group
Publikováno v:
BMC Emergency Medicine, Vol 21, Iss 1, Pp 1-10 (2021)
BMC Emergency Medicine, 21(1):61. BioMed Central Ltd
BMC Emergency Medicine
BMC emergency medicine, 21(1):61. BioMed Central
BMC Emergency Medicine, 21(1):61. BioMed Central Ltd
BMC Emergency Medicine
BMC emergency medicine, 21(1):61. BioMed Central
Background During the COVID-19 pandemic, a decrease in the number of patients presenting with acute appendicitis was observed. It is unclear whether this caused a shift towards more complicated cases of acute appendicitis. We compared a cohort of pat
Publikováno v:
Bravenboer, N, Oostlander, A E & Van Bodegraven, A A 2021, ' Bone loss in patients with inflammatory bowel disease : Cause, detection and treatment ', Current Opinion in Gastroenterology, vol. 37, no. 2, pp. 128-134 . https://doi.org/10.1097/MOG.0000000000000710
Purpose of the review Inflammatory bowel disease (IBD) is associated with bone loss leading to osteoporosis and increased fracture risk. Bone loss is the result of changes in the balanced process of bone remodeling. Immune cells and cytokines play an
Autor:
Jan van den Brande, Tessa Uiterwaal, Christianne J. Buskens, Juda Vecht, Robert E G J M Pierik, Job H.C. Peters, Nofel Mahmmod, John Maring, E. Joline de Groof, Toer W. Stevens, H. B. A. C. Stockmann, Pieter C. F. Stokkers, Karlien F. Bruin, Eric J. Hazebroek, Ailsa Hart, Arnold van de Laar, Hubert A Prins, Richard van Hillegersberg, Rachel L. West, Paul Kingma, Menno A. Brink, Pritesh Morar, Ruud Schouten, Marno C.M. Rijk, A Jeroen de Groof, Sijbrand Hofker, Annekatrien Depla, Bregje Mol, Janneke van der Woude, T. J. Gardenbroek, Janindra Warusavitarne, Bas Oldenburg, Edwin S. van der Zaag, Anna A. W. van Geloven, Rogier M P H Crolla, Emma J. Eshuis, Hans Brouwer, Meindert N. Sosef, Maria L Haasnoot, Geert R. D'Haens, Nynke Talstra, Marcel Spanier, Liekele Oostenbrug, Jeroen M. Jansen, Maarten J Boom, Donald L. van der Peet, Nanne K. H. de Boer, Willem A. Bemelman, Cyriel Y. Ponsioen, Rosalie C Mallant, Theo J.M. van Ditzhuijsen, Gerard Dijkstra, Alexander P.J. Houdijk, Willem A. Marsman, Djuna Cahen, Casper G. Noomen, Huib A. Cense, Esther C. J. Consten, Michael F. Gerhards, Ad A. van Bodegraven, Rob J. Lieverse, Andreas Marinelli, Sjoerd van der Werff, Clemens Bolwerk, Ernst Jan Spillenaar Bilgen, Quirijn A. J. Eijsbouts, Guido Mannaerts, Bart A. van Wagensveld
Publikováno v:
The lancet. Gastroenterology & hepatology, 5(10), 900-907. HANLEY & BELFUS-ELSEVIER INC
LIR!C study group 2020, ' Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease : retrospective long-term follow-up of the LIR!C trial ', The Lancet Gastroenterology and Hepatology, vol. 5, no. 10, pp. 900-907 . https://doi.org/10.1016/S2468-1253(20)30117-5
The Lancet Gastroenterology and Hepatology, 5(10), 900-907. Elsevier Ltd
lancet. Gastroenterology & hepatology, 5(10), 900-907. Elsevier Limited
LIR!C study group 2020, ' Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease : retrospective long-term follow-up of the LIR!C trial ', The Lancet Gastroenterology and Hepatology, vol. 5, no. 10, pp. 900-907 . https://doi.org/10.1016/S2468-1253(20)30117-5
The Lancet Gastroenterology and Hepatology, 5(10), 900-907. Elsevier Ltd
lancet. Gastroenterology & hepatology, 5(10), 900-907. Elsevier Limited
BACKGROUND: The LIR!C trial showed that laparoscopic ileocaecal resection is a cost-effective treatment that has similar quality-of-life outcomes to treatment with infliximab, an anti-tumour necrosis factor (TNF) drug. We aimed to compare long-term o
Autor:
Gerard Dijkstra, Andrea E. van der Meulen-de Jong, Herma H. Fidder, M. W. M. D. Lutgens, Lennard P L Gilissen, Nofel Mahmmod, J Schultheiss, Shaden Mahmmod, Frank Hoentjen, Adriaan C I T L Tan, Lisa J T Smits, Bas Oldenburg, Ad A. van Bodegraven
Publikováno v:
Inflammatory Bowel Diseases, 27(12), 1954-1962. OXFORD UNIV PRESS INC
Inflammatory Bowel Diseases, 27, 1954-1962
Inflammatory Bowel Diseases, 27(12), 1954-1962. LIPPINCOTT WILLIAMS & WILKINS
Inflammatory Bowel Diseases, 27, 12, pp. 1954-1962
Inflammatory Bowel Diseases, 27, 1954-1962
Inflammatory Bowel Diseases, 27(12), 1954-1962. LIPPINCOTT WILLIAMS & WILKINS
Inflammatory Bowel Diseases, 27, 12, pp. 1954-1962
Background Patients suffering from inflammatory bowel diseases (IBD) and treated with originator infliximab are increasingly being switched to biosimilars. Some patients, however, are “reverse switched” to treatment with the originator. Here we a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65b46bb5e73e3a6fedc98560df43246e
http://hdl.handle.net/1887/3276514
http://hdl.handle.net/1887/3276514
Publikováno v:
Osteoporosis International
van Bodegraven, A A & Bravenboer, N 2020, ' Perspective on skeletal health in inflammatory bowel disease ', Osteoporosis International, vol. 31, no. 4, pp. 637-646 . https://doi.org/10.1007/s00198-019-05234-w
Osteoporosis International, 31(4), 637-646. SPRINGER LONDON LTD
van Bodegraven, A A & Bravenboer, N 2020, ' Perspective on skeletal health in inflammatory bowel disease ', Osteoporosis International, vol. 31, no. 4, pp. 637-646 . https://doi.org/10.1007/s00198-019-05234-w
Osteoporosis International, 31(4), 637-646. SPRINGER LONDON LTD
Osteopenia and osteoporosis are common features in inflammatory bowel disease (IBD), comprising both Crohn's disease and ulcerative colitis. Moreover, Crohn's disease is associated with increased fracture risk. The etiology of bone loss in IBD is mul
Autor:
Jessy V. van Asperen, Miriam E. van Strien, Emma J. van Bodegraven, Coen B J van Deursen, Oscar M. J. A. Stassen, Pierre A. Robe, Elly M. Hol, Jacqueline A. Sluijs
Publikováno v:
The FASEB Journal, 33(11), 12941-12959. FASEB
Gliomas are the most common primary brain tumors. Their highly invasive character and the heterogeneity of active oncogenic pathways within single tumors complicate the development of curative therapies and cause poor patient prognosis. Glioma cells
Autor:
Virag Sagi-Kiss, Anneleen Vandewynkel, Wim Verbeke, Panagiotis Georgiadis, Giovanni Parolari, Ad A.M. Masclee, Mary H. Ward, Autumn G Hullings, James J. Goedert, Jan-Hein van Helvoirt, Yunhu Wan, Giovanna Saccani, Roberta Virgili, Richard van der Kruijk, Karen Mathijs, Yung Hung, Xing Hua, Doratha A. Byrd, Rashmi Sinha, Gert Hemke, Carla B.E.M. Vleugels-Simon, Ni Zhao, Harm-Jan Pieters, Frans Egberts, Gunter G. C. Kuhnle, Adriaan A. van Bodegraven, Simone G. J. van Breda, Dirk Dobbelaere, Theo M. de Kok, Rob Knight
Publikováno v:
Environmental Research, 197:111084. Elsevier Science
Environ Res
Environ Res
Background One mechanism that can explain the link between processed meat consumption and colorectal cancer (CRC) is the production of carcinogenic N-nitroso compounds (NOCs) in the gastrointestinal tract. Oral and gut microbes metabolize ingested pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c5b2185cdbd63774ae9186b11240ca3
https://cris.maastrichtuniversity.nl/en/publications/89c8e675-0846-45fd-b2d6-88f123b252e3
https://cris.maastrichtuniversity.nl/en/publications/89c8e675-0846-45fd-b2d6-88f123b252e3
Autor:
Marie J. Pierik, Tamara Munnecom, Paul J. Boekema, Daisy Jonkers, Mariëlle Romberg-Camps, Ad A. van Bodegraven, Laura Janssen, Manuela A. Joore, Michèl Aquarius, Lloyd Brandts, Jeoffrey J L Haans, Adrian A. M. Masclee
Publikováno v:
BMJ Open, 11(5):042885. BMJ Publishing Group
BMJ Open, Vol 11, Iss 5 (2021)
BMJ Open
BMJ Open, Vol 11, Iss 5 (2021)
BMJ Open
IntroductionCrohn’s disease (CD) is a chronic inflammatory bowel disease with a heterogeneous clinical presentation, relapse rate and treatment response. At present, no markers are available to adequately predict disease course at diagnosis. To pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::082cad4540ff81c812c4b0ebca66caee
https://cris.maastrichtuniversity.nl/en/publications/81594221-89e3-447d-8ffe-d421ae541a5a
https://cris.maastrichtuniversity.nl/en/publications/81594221-89e3-447d-8ffe-d421ae541a5a
Autor:
Birgit I. Lissenberg-Witte, Joanne Verheij, Bindia Jharap, Maurice G. Russel, Elisabeth Bloemena, Dirk P. van Asseldonk, Gijsbert den Hartog, Nanne K. H. de Boer, Melek Simsek, Dik B. Westerveld, Carin M.J. van Nieuwkerk, Adriaan A. van Bodegraven, Marco C. Becx, Chris J. J. Mulder
Publikováno v:
Scandinavian Journal of Gastroenterology, 54(6), 753-760. Informa Healthcare
van Asseldonk, D P, Simsek, M, de Boer, N K H, Jharap, B, Bloemena, E, den Hartog, G, Westerveld, D B, Becx, M C, Russel, M G, Lissenberg-Witte, B I, van Nieuwkerk, C M, Mulder, C J J, Verheij, J & van Bodegraven, A A 2019, ' Limited relevance and progression of histological alterations in the liver during thioguanine therapy in inflammatory bowel disease patients ', Scandinavian Journal of Gastroenterology, vol. 54, no. 6, pp. 753-760 . https://doi.org/10.1080/00365521.2019.1629006
Scandinavian journal of gastroenterology, 54(6), 753-760. Informa Healthcare
van Asseldonk, D P, Simsek, M, de Boer, N K H, Jharap, B, Bloemena, E, den Hartog, G, Westerveld, D B, Becx, M C, Russel, M G, Lissenberg-Witte, B I, van Nieuwkerk, C M, Mulder, C J J, Verheij, J & van Bodegraven, A A 2019, ' Limited relevance and progression of histological alterations in the liver during thioguanine therapy in inflammatory bowel disease patients ', Scandinavian Journal of Gastroenterology, vol. 54, no. 6, pp. 753-760 . https://doi.org/10.1080/00365521.2019.1629006
Scandinavian journal of gastroenterology, 54(6), 753-760. Informa Healthcare
Background: Thioguanine is associated with liver toxicity, especially nodular regenerative hyperplasia (NRH). We assessed if liver histology alters during long-term maintenance treatment with thioguanine in patients with inflammatory bowel disease (I